The forum on "China's Intellectual Property-related Reform Measures and New Trends in Patent Litigation" will be held successfully!
Types of patents that are easily overlooked- Design Patent
Colopl Settles Patent Infringement Lawsuit with Nintendo by Paying $30 Million
The First COVID-19 Vaccine Approved by FDA
Can artificial intelligence (AI) be patent inventors?
Huawei and Verizon, patent litigation to reconciliation
Kerendia Receives FDA Approval for Slowing chronic kidney disease in Type 2 Diabetes
FDA approves the first C3 inhibitor for adults with serious rare blood disease
Hengrui Medicine's application for the listing of CDK4/6 inhibitors has been accepted
2001, 20th Floor, Block B, Ascendas Building, No. 88 Jiangmiao Road, Jiangbei New District, Nanjing City, Jiangsu Province
Copyright ◎Nanjing Huaxun Intellectual Property Consultant Co., Ltd.
苏ICP备xxxxxx号-1 Powered by： www.300.cn